ABSTRACT We have investigated the role of retinoic acid (RA) in eye development using the vitamin A deficient quail model system, which overcomes problems of retinoic acid synthesising enzyme redundancy in the embryo. In the absence of retinoic acid, the ventral optic stalk and ventral retina are missing, whereas the dorsal optic stalk and dorsal retina develop appropriately. Other ocular abnormalities observed were a thinner retina and the lack of differentiation of the lens. In an attempt to explain this, we studied the expression of various dorsally and ventrally expressed genes such as Pax2, Pax6, Tbx6, Vax2, Raldh1 and Raldh3 and noted that they were unchanged in their expression patterns. In contrast, the RA catabolising enzymes Cyp26A1 and Cyp26B1 which are known to be RA-responsive were not expressed at all in the developing eye. At much earlier stages, the expression domain of Shh in the prechordal plate was reduced, as was Nkx2.1 and we suggest a model whereby the eye field is specified according to the concentration of SHH protein that is present. We also describe another organ, Rathke's pouch which fails to develop in the absence of retinoic acid. We attribute this to the down-regulation of Bmp2, Shh and Fgf8 which are known to be involved in the induction of this structure.
Introduction
The development of the eye has long been known to be dependent upon retinoic acid signalling, since a litter of pigs without eyes was born to a sow kept on a vitamin A deficient diet (Hale 1933) . Subsequent vitamin A deficiency studies, mostly using rats, have revealed a range of ocular defects probably depending upon the level of deficiency including microphthalmia, coloboma, abnormal folding of the retina, anterior chamber defects, gaps between the neural and pigmented retina, thickened retrolenticular membrane filling the vitreous cavity, delayed lens differentiation and a denser periocular mesenchyme (Warkany and Schraffenberger 1946; Warkany et al. 1948; Wilson et al. 1953; Dickman et al. 1997; ) . The reason why the eye is so susceptible to RA deficiency is most likely because it is a site of intense RA synthesis as all the RA synthesising and catabolising enzymes are expressed there. RA can be detected in both the dorsal and ventral regions of the eye (Marsh-Armstrong et al. 1994; McCaffery et al. 1992 ) and the relative amounts change with developmental age (McCaffery et al. 1993; Mey et al. 1997) . The RA-synthesising enzyme Raldh1 is expressed in the dorsal retina (McCaffery et al. 1991; McCaffery et al. 1992; Godbout et al., 1996) , Raldh3 is expressed in the ventral retina (McCaffery et al. 1999; Grun et al. 2000; Mic et al. 2000; Suzuki et al. 2000) and Raldh2 is expressed in the optic vesicle (Haselbeck et al. 1999) , at the ventral edge of the eye field (McCaffery et al. 1999) and in the periocular mesenchyme (Niederreither et al. 1997; Blentic et al., 2003) . Cyp26A1 is expressed in an equatorial region of the mouse eye between the dorsal Raldh1 and ventral Raldh3 synthetic domains (Fujii et al. 1997; de Roos et al. 1999; McCaffery et al. 1999; Wagner et al. 2000) , a function fulfilled by Cyp26B1 and C1 in the chick embryo (Reijntjes et al. 2003; Reijntjes et al. 2004 ) thus creating a RA free region and dividing the eye into three zones.
It was expected therefore that these domains of local RA generation would be involved in patterning the developing eye or perhaps the subsequent retinotectal connections in the dorsoventral (DV) axis. However, individual knockouts of the genes coding for these enzymes have failed to generate dramatic phenotypes probably because each enzyme can compensate for the others in this site of multiple enzyme expression. Thus Raldh1-/-mice have normal eyes and retinotectal connections, unaltered expression of dorsal patterning genes such as Tbx5 and, most surprisingly, the early dorsal retina still activated the RARElacZ reporter gene, demonstrating normal levels of RA synthesis (Fan et al. 2003) . The latter could be produced by a transient domain of expression of Raldh3 in the dorsal retinal pigmented epithelium as RA activity at later stages did disappear in the Raldh1-/-eye. The Raldh3-/-embryo has a mild shortening of the ventral retina, an abnormal retrolenticular membrane and thickening of the ventral periocular mesenchyme caused by the absence of apoptosis (Dupe et al., 2003; Matt et al. 2005) . Patterning gene expression domains such as Vax2 (ventral) and Tbx5 (dorsal) were unaffected. The Raldh2-/-embryonic eye had a defect. Here, the optic vesicle failed to invaginate into the optic cup and no lens formed suggesting a role for RA in this early morphogenetic event (Mic et al. 2004) . However, again various eye genes were expressed in their normal domains -Pax6, Six3, Rx and Mitf and it seems that the presence of normal levels of Raldh1 and Raldh3 in the developing retina compensates for the loss of RA synthesised by Raldh2 (Matt et al., 2005) . Rahlh1/Raldh3 double mutant embryos showed a greater degree of abnormality in the same structures as the single Raldh3 mutant with no additional regions of abnormality and, again, patterning genes such as Tbx5, Vax2 and Pax2 were normal (Matt et al., 2005; Molokov et al., 2006) . This suggests a functional redundancy between these two Raldhs. In the triple mutant there is the first suggestion of a failure of patterned structures with the ventral optic cup failing to invaginate although these embryos had been partially rescued by maternal provision of RA (Molotkov et al., 2006) . Here again, the ventral gene Vax2 was still expressed.
Patterning defects as well as general growth failures have also been reported in retinoic acid receptor (RAR) and retinoid X receptor (RXR) null mutant mice. The least affected single mutants were the RARβ-/-embryos which displayed an abnormal retrolenticular mass of pigmented tissue in the anterior chamber of the eye . The most affected single mutants were the RXRα-/-mice which displayed abnormal eyelids, agenesis of the anterior chamber of the eye, coloboma of the optic nerve and shortening of the ventral retina (Kastner et al. 1994) . These RXR abnormalities were increased in a graded manner in double mutant embryos. Thus the RARβ/RARγ mutants, RXRα/RARγ or RXRα/RARα mutants had a very much smaller ventral retina as well as more severe anterior chamber abnormalities (Kastner et al. 1994; Lohnes et al. 1994; Kastner et al. 1997) . Therefore from the point of view of patterning, the ventral retina seems to require RXRα and RARγ or RARα and it is surprising that such a defect had not been seen in vitamin A deficient (VAD) studies as the RAR/RXR knockouts are generally considered to recapitulate all of the VAD phenotypes.
However, a ventral abnormality has been seen after inhibition of RA synthesis with citral, a competitive inhibitor of the aldehyde dehydrogenases. When administered to the zebrafish embryo this compound caused a complete failure of the ventral half of the eye to develop leading to dorsal half eyes (Marsh-Armstrong et al. 1994) . Another striking patterning result in zebrafish is the converse, namely a duplicated double eye which developed after systemic treatment of embryos with RA at a precise time during early somitogenesis (Hyatt et al. 1992) . These duplicated eyes showed the characteristics of double ventral eyes and local application of RA to the dorsal eye induced an ectopic choroid fissure (Hyatt et al. 1996) . Since the usual effect of excess RA administered to other vertebrate embryos is absence of eyes or microphthalmia (Shenfelt 1972; Rosa et al., 1986; Durston et al. 1989; Sive et al. 1990; Sulik et al. 1995; Eagelson et al., 2001) it is important to consider whether these fascinating patterning results on zebrafish are unique to that species or more generally applicable.
To this end we have examined eye development in VAD quail embryos. These embryos are derived from adults fed a VAD diet and contain no detectable retinoids (Dong and Zile 1995; Chen et al. 1996) . Since the supply of RA is eliminated, this model system abrogates the problem of redundancy of the RA synthesising enzymes or the RA receptors. We and others have used this model system extensively to characterise the regions of the early embryo which develop abnormally in the absence of RA. These include the cardiovascular system , the somites (Maden et al. 2000) , the hindbrain (Maden et al. 1996; Gale et al. 1999; ) , the pharyngeal arches (Quinlan et al. 2002) and spinal cord (Wilson et al. 2004) . We report the observation that the VAD quail fails to develop the ventral part of the retina including the choroid fissure and that this is likely to be caused by an earlier defect at the ventral midline of the developing central nervous system involving a narrowing of the Shh domain. This is the first report of such an abnormality in a VAD system and accords with the receptor knockout studies on mouse and the zebrafish inhibition studies described above. We also report that Rathke's pouch, part of the system which produces the pituitary, is also absent in these embryos, highlighting another organ whose development depends upon RA signalling.
Results

Histological observations
In unstained, fixed embryos it is possible to see the basic structure of the developing eye (Fig. 1A) . The bilayered retina with the ventral choroid fissure (arrowhead, Fig. 1A ) gives the eye a tear-drop shape and the lens fills up the internal space. It was readily apparent that the eyes of VAD embryos were highly abnormal (Fig. 1B) . The retina seemed to be much thinner than normal creating a larger ocular space in which the lens was floating and most strikingly there seemed to be a complete absence of the choroid fissure. Thin plastic sections were prepared in order to confirm these impressions. Fig. 1F shows a normal quail stage 20 eye. The neural and pigmented retina are fused together, there is a normal choroid fissure (Fig. 1G ) and the eye is surrounded by neural crest derived periocular mesenchyme. In the stage 20 VAD eye the neural retina is not completely fused to the pigmented retina, the lens is not solid but has a cavity in the middle and the whole of the ventral part of the eye is missing including the choroid fissure (Fig. 1H) . A close up of the ventral region shows apoptotic cells with condensed spherical nuclei (Fig. 1I, J) .
It is possible to rescue these VAD embros with a single injection of retinol prior to the 5-6 somite stage whereupon all the abnormalities in the different organ systems are completely corrected (Gale et al., 1999) . This confirms that the abnormalities are due to the lack of retinoids rather than any other secondary alteration. We performed such rescues here with a single injection of retinol prior to stage 8 into VAD embryos and in unstained specimens it was clear that the eyes had recovered (Fig. 1C ). There was a choroid fissure present (arrowhead, Fig. 1C ), the retina was thick and the lens filled the ocular space. We also allowed some embryos to grow up for a considerably longer period of time to ensure that the eyes continued normal development. It is striking that after a single injection of retinol the embryos continued to develop normally, forming perfect embryonic structures including the eyes on day 7 (Fig. 1D, E) . Such older embryos were, however, often slightly smaller in overall dimensions than normal.
Gene expression analyses
Because of this failure of the ventral part of the eye including the optic fissure to form in VAD embryos we examined the expression of genes known to be expressed dorsally and ventrally and potentially involved in patterning of the early eye. In these gene expression analyses 3-5 embryos per stage were used.
We first examined the two retinoic acid synthesising enzymes which are expressed in dorsal and ventral domains, namely Raldh1 and Raldh3. Raldh1 was expressed in the VAD embryo at the normal time, around stage 12 and in its normal dorsal domain ( Fig. 2A, B ) although the expression extended slightly further ventrally as if the dorsal domain was larger than normal. With examined the expression of this gene in normal and VAD eyes. Pax6 expression begins in the anterior neuroepithelium at stage 8 in both normal and VAD embryos (data not shown). Subsequently when the optic vesicle appears, expression is the same in normal and VAD embryos and remains similar even when the VAD abnormalities have appeared (Fig. 2E, F) . Another gene expressed dorsally that we examined was Tbx5. This gene is expressed later than Pax6 and is confined to the dorsal retina. Again its expression still appeared in the VAD embryo and in the normal dorsal location (Fig. 2G, H) .
Two ventrally expressed patterning genes were examined next. The first was Pax2 which is involved in the outgrowth of the proximal part of the eye vesicle from the forebrain, that is the optic stalk. It begins to be expressed in both the normal and VAD isthmus at stage 10 (data not shown) and at stage 14 when Pax2 expression is strong in the ventral region of the normal eye it is still expressed in the VAD eye even though the eye cup is clearly thinner and the ventral part is deficient (Fig. 2I , J). At stage 18 when the normal choroid fissure has formed ( Fig. 2K ) there is still expression in the VAD eye even though there is clearly no fissure (Fig. 2L) .
The second ventral gene examined was Vax2 whose expression began in the normal quail eye around stage 14 (Fig. 2M) . Expression in the VAD eye did not appear at this stage ( Fig. 2N ), but by stage 18-20 when normal Vax2 expression was in the regard to the ventrally expressed Raldh3, one might have predicted that it would not appear at all in VAD embryos but this was clearly not the case (Fig. 2C, D) . However, in the normal eye there is a mid-ventral gap in expression caused by the developing choroid fissue (Fig. 2C , arrowhead) which is not apparent in the VAD eye where the expression is continuous because there is no choroid fissure (Fig. 2D) . The ventral ectodermal expression domain of Raldh3 which will eventually move into the nasal pit and Rathke's pouch is also noticeably smaller in the VAD embryo at this stage (Fig. 2D, arrow) . Therefore neither of these enzymes are regulated by the absence of their substrate, but both suggest an alteration of the structure of the eye in the ventral region.
Pax6 is a gene crucially involved in the development of the distal retina and whose expression subsequently becomes localised to the dorsal part of the retina. We ventral region including the choroid fissure (Fig. 2O ) the VAD eye had begun to show some expression (Fig. 2P) . Thus the expression of Vax2 was delayed in the VAD eye rather than absent. Two other enzymes involved in RA metabolism are expressed in the avian eye, Cyp26A1 and Cyp26B1 and their expression was also examined. They have slightly different expression patterns from their equivalent genes in the mouse embryo, but both are induced by RA (Reijntjes et al., 2005) . Cyp26A1 is expressed in the dorsal part of the lens and also in a small domain in the ventral part (Fig. 2Q ). This expression is absent in the VAD lens (Fig. 2R) . Cyp26B1 is expressed in an equatorial region of the avian neural retina (Fig. 2S) . This is the domain of expression of Cyp26A1 in the mouse embryo. In the VAD eye Cyp26B1 fails to be expressed at all (Fig. 2T ). As they are RA-inducible enzymes, these results imply that both of these domains arise as a result of local RA synthesis
Ventral midline defects
The lack of any alterations in these patterning genes, apart from the RA-inducible Cyp26 genes, suggested that the defect which arose in VAD embryos was realised prior to their appearance. We therefore looked for early anatomical abnormalities and since the eye fields arise from one single midline field under the influence of the prechordal plate (Li et al., 1997) we examined midline structures. Indeed, on closer examination of the ventral aspect of VAD embryos it became clear that they were narrower in the mediolateral dimension as can be seen by comparing Fig. 3A and 3B. These images are of Raldh3 in situs, both taken at the same magnification and show that the overall width of the VAD embryo is less, as well as the width of the posterior projecting domain of Raldh3 expression (bracket in Figs. 3A, B) . This could be caused by a loss of tissue and/or decreased signalling at the ventral midline leading to the loss of the ventral part of the evaginating optic primordium. To test this possibility we examined the expression of Shh over these early stages of development in precisely staged pairs of embryos. No difference could be detected in Shh expression between normal and VAD embryos at pre-somite stages or early somite stages. Fig 3J) . This confirms that RA controls gene expression locally rather than globally. Another ventral midline gene, Nkx2.1 was also virtually eliminated in the anterior head region by stage 18 (Fig. 3 K -L , arrowheads in 3L), but not more posteriorly in the hindbrain (arrow in Fig. 3L ).
Another abnormal region -Rathke's pouch
This missing region of the ventral eye corresponded precisely to the domain of Raldh3 expression (Fig. 4A) . It is possible, therefore, that Raldh3 expression might serve as a marker for regions of the embryo which are also abnormal in the absence of RA. In the head region there are three regions in addition to the ventral eye which express Raldh3, namely the isthmus, the otic vesicle and Rathke's pouch (Grun et al., 2000) (Fig. 4B) . The otic vesicle is certainly abnormal and fails to invaginate (Maden et al., 1996; Kil et al. 2005) supporting the idea that Raldh3 serves as a marker of abnormality. On closer examination of the isthmus we could detect no obvious differences between normal and VAD embryos, although a full gene expression and anatomical analysis was not performed. It remains possible that there may be differences to be found in the future and the Raldh3 knockout mouse would be a valuable resource for looking at this.
With regard to Rathke's pouch this structure was clearly dependent on RA provided by Raldh3 because it was entirely absent in VAD embryos. Fig. 4C shows a sagittal section through a normal stage 20 embryo in which the expression of Raldh3 is precisely in Rathke's pouch. Fig. 4D shows a histological section of a normal embryo revealing the in-pushing of the oral epithelium (arrow in Fig. 4D ) which creates Rathke's pouch by coming into contact with the thickened ventral forebrain neural epithelium (arrowhead in Fig. 4D ). In contrast, a similar section through a VAD embryo (Fig. 4E) shows a thinner forebrain neuroepithelium with no sign of a thickening and an oral epithelium which shows no sign of an in-pushing. This suggests that the early development of the pituitary in terms of these cell interactions and morphogenetic movements is dependent upon RA synthesised by Raldh3. Bmp2 and Fgf8 are two genes which are involved in the neuroepithelium/oral epithelium interaction to instigate early pituitary gland development (reviews, Dasen & Rosenfeld, 1999; Sheng & Westphal, 1999 ) so we examined their expression in normal and VAD quail embryos. The wholemount in Fig.  4F shows the normal expression of Bmp2 in Rathke's pouch (arrows in Fig. 4F ) and the rest of the head region including the 1 st branchial arch (arrowhead in Fig 4F) . The absence of Bmp2 expression in the region of Rathke's pouch in the VAD embryo is revealed in Fig. 4G (arrows) , but its continued expression in the 1st branchial arch (arrowheads in Fig. 4F & G) . Again, this demonstrates local not global control of gene expression by RA. Fgf8 expression is present in the normal oral epithelium (Fig. 4H, arrow) including the epithelium of the first branchial cleft. This expression is down-regulated in the VAD embryo leaving a small patch of Fgf8 on the external epithelium of the cleft (Fig. 4I, arrow) , but other regions such as the isthmus are not affected. As we observed earlier (Fig. 3I, J) Shh expression, which is another gene involved in pituitary development by 
Discussion
Redundancy among the RA synthesising enzymes, the RALDHs, has made it very difficult to pursue studies on the function of RA in the developing eye as all three Raldhs are expressed there. The absence of one enzyme is compensated for by the presence of at least two others (Sakai et al. 2004; Matt et al., 2005) . This has led to the conclusion that RA is not involved in DV specification of the eye despite the observations in the zebrafish embryo that in the presence of excess RA a double ventral eye forms with an expanded optic stalk (Hyatt et al., 1996) and in the presence of citral the ventral half of the eye fails to form (Marsh-Armstrong et al., 1994) . To overcome these redundancy problems we have examined eye development in the VAD quail embryo which develops in the absence of RA, by removing the source of RA, namely retinol, from the diet. Under these circumstances none of the RALDHs can function due to the absence of substrate, a situation equivalent to a multiple gene knockout. As a result we find that the ventral half of the eye including the choroid fissure fails to develop and some of the cells in that region undergo apoptosis, presumably those that have failed to be specified appropriately. The remaining portion of the neural and pigmented retina are much thinner than normal and there is no real fusion between these two layers. The optic space appears larger and the eye looks empty. The lens still forms although it is more vacuolated rather than being densely packed with cells and perhaps crystallin synthesis, which is known to be regulated by RA (Tini et al. 1993) , is downregulated. We conclude therefore that RA is required for the specification of the ventral retina, the ventral optic stalk and the choroid fissure, the proliferation and growth of the retina and the differentiation of the lens. It is surprising that such a major defect in the eye structure such as a missing ventral half of the retina and ventral optic stalk has not been seen before in VAD studies in mammals. Only microphthalmia, amongst other defects, has been reported (Warkany and Schraffenberger 1946; Warkany et al. 1948; Wilson et al. 1953; Dickman et al. 1997) . It could well be that the histological structure of such eyes has not been studied and that they were, in fact, missing ventral tissue although a general growth inhibition caused by reduced RA signalling is also a possibility (Sen et al. 2005) . It is also possible that they were not completely VAD but only partially so and a general growth inhibition to produce microphthalmic eyes occurs at low RA levels, but for ventral defects the absence of RA is required. Curiously, microphthalmia is the classical response of the eye to excess RA signalling caused by altered specification of the neural plate and most clearly seen in Xenopus (Durston et al., 1989; Manns and Fritzsch 1991; Eagelson et al., 2001) , caused by a down-regulation of Pax6 and a forebrain marker Xbf1 (Eagleson et al., 2001) . But in neither of these situations have patterning aspects of microphthalmic eyes been fully studied so it is not possible yet to determine whether excess RA and a deficiency of RA generate the same precise patterning alterations.
The failure of proliferation of the neuroepithelium is not unique to the retina, but has been observed throughout the CNS ( 
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its proliferation rate as normal embryo do and as a result the whole neuroepithelium remains a thin tissue. The effect on the lens, however, is specific to the eye because RA is involved in lens development not only because of its ability to regulate crystallin synthesis (Tini et al., 1993) , but also because the optic cup and lens is a site of intense RA signalling activity (Enwright and Grainger 2000) . In this region, RA signalling is down-regulated in the small eye (Pax6) mutant so RA seems to be downstream of Pax6 which explains why Pax6 expression seemed unaffected in the VAD embryo. Indeed, neither Raldh1 nor Raldh3 appear in the Pax6 rat mutant (Suzuki et al. 2000) . A more dramatic effect of lack of RA signalling on the lens has been seen in mouse embryos where antisense oligonucleotides to retinol binding proteins were injected into the yolk sac. In this case there was a complete failure of lens induction (Bavik et al. 1996) . We examined several other genes thought to be involved in DV specification of the eye, such as Pax2, Tbx5 and Vax2 and found them also to be expressed in their normal domains, although Vax2 was delayed in its appearance. Tbx5 and Vax2 begin to be expressed quite late in development (stage 14) and so these are unlikely to be involved in eye field specification. Neither was there any change in the expression of these two genes in experiments where RA signalling was reduced using a dnRARα construct (Sen et al., 2005) . On the contrary, Vax2 regulated the expression of the RA synthesising enzymes Raldh1 and Raldh3 which is why we saw no change in these two gene expression domains. There was obviously no effect of lack of substrate on the expression of these two enzymes. On the other hand, the two RA catabolising enzymes Cyp26A1 and Cyp26B1 were not expressed so their expression does depend on substrate availability which might be expected since these enzymes are induced by RA (Reijntjes et al. 2005) . Figure 5 depicts a summary diagram of the normal eye ( Fig.  5A ) and the parts that are missing in the VAD eye (Fig. 5B) namely the ventral optic stalk and ventral retina. This is clearly a patterning defect rather than a proliferation defect and it is interesting to hypothesise how this may have come about. The early eye field is specified as a single unit within the neural plate which splits under the influence of the prechordal plate to emerge as two separate fields (Li et al., 1997) . Within this emerging eye field RA may be responsible for specifying the ventral optic stalk and ventral retina domains. Pax2 is expressed in the optic stalk (Macdonald et al., 1995) and the failure of this gene to be expressed could be responsible, but Pax2 is expressed in these VAD quails and they are not cyclopic. It is more likely that there is some graded explanation for this phenotype rather than an all-ornone phenomenon and Shh is a likely candidate as it controls DV polarity of the eye in a concentration dependent fashion (Lupo et al. 2005) .
Shh is expressed in the midline prechordal plate and induces Pax2 and optic vesicle outgrowth. In the absence of Shh the splitting of the optic vesicles from the single eye field does not take place and cyclopia results (Chiang et al., 1996) . Nevertheless distal retinal tissue forms, albeit in the wrong location because of the failure of optic stalk tissue to be induced. Conversely overexpression of Shh causes an expansion of the Pax2 domain and other ventral markers including Raldh3, resulting in expanded optic stalks and small eyes due to overproduction of ventral tissue (Ekker et al., 1995; Macdonald et al., 1995; Lupo et al., 2005) and in the chick embryo the ventral retina is replaced by the optic stalk (Zhang & Yang, 2001) . Shh signalling acts in a graded way to induce these optic fates: at the highest Shh levels ventral optic stalk is induced, at lower levels ventral retina is induced and the dorsal retina is unaffected by loss of Shh as is Pax6 expression (Chow & Lang, 2001; Lupo et al., 2005;  Fig. 5C ). In vivo there is a high medial to low lateral gradient of Ptc mRNA, the SHH receptor, along the optic stalk (Zhang & Yang, 2001 ). Thus to explain these eye defects we reasoned that Shh levels may be altered in the VAD quails, but certainly not obliterated as the embryos were not cyclopic. This is indeed what was observed. Shh expression was at similar levels, but in a narrower band of prechordal plate mesoderm which would presumably result in overall lower levels of SHH protein concentrations (Fig. 3 E vs F and G vs H) . This would lead to the loss of ventral optic stalk, ventral retina, the preservation of the dorsal retina (Fig. 5C ), all of which would occur, not in the absence of Pax2, but at lower levels. If we hypothesise that specification of the dorsal optic stalk takes place at SHH levels intermediate between ventral retina and dorsal retina then the VAD phenotype becomes explicable, based on lowered SHH levels (Fig. 5C) . In fact the VAD quails are remarkably similar to the cyclops zebrafish phenotype which is characterised by reduced Shh expression, reduced Pax2 expression and reduced optic stalks (Macdonald et al., 1995) .
In eye development RA thus plays a continuing sequence of roles. The first is an early role, at gastrulation stages, perhaps to Hypothesis to explain the VAD eye phenotype based on the levels of SHH protein (red gradient). In the normal embryo the dorsal retina (DR) develops irrespective of SHH levels, the dorsal optic stalk (DOS) develops at low levels of SHH, the ventral retina (VR) at intermediate levels and the ventral optic stalk (VOS) at the highest levels. Right drawing: under VAD conditions the levels of SHH are much lower than normal and only the dorsal optic stalk is specified.
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regulate the amount of mesoderm which enters the prechordal plate. Fewer prechordal plate cells will produce a smaller total amount of SHH protein resulting in the failure of the ventral optic stalk specification or outgrowth. Alternatively there could be reduced levels of prechordal plate signalling in the absence of RA. Indeed, a RA synthesising enzyme, Raldh3 is expressed during gastrulation in Hensen's node (Maden 2004) and in the dorsal lip of the blastopore (Lupo et al., 2005) and early prechordal plate abnormalities in size and signalling properties have been reported in VAD quails (Halilagic et al. 2003) . A later role for RA, in addition to retinal growth control, is one we have not approached here and concerns DV pattering of the retina and the retinotopic map through the regulation of the expression of EphB2, EphB3 and ephrinB2 (Sen et al., 2005) . Here again, the absence of altered retinotopic maps in Raldh mutant mice may be due to redundancy.
A further defect in the craniofacial region that we observed in these VAD embryos was the failure of Rathke's pouch to develop. The oral epithelium failed to invaginate and approach the ventral forebrain neuroepithelium such that the normally close interaction which results in the development of the pituitary gland could not occur. In contrast to the eye patterning defects, this abnormality has been seen in single Raldh mutants, in this case the Raldh2-/-embryo (Ribes et al. 2006) . In the region of Rathke's pouch we observed a loss of Shh, Nkx2.1, Bmp2 and Fgf8 expression. Each of these genes is known to play a role in the early development of the pituitary gland. Shh expression creates a boundary between the oral epithelium and Rathke's pouch epithelium which acts as an organising centre for further gene induction as well as being expressed in the ventral diencephalon (Treier et al., 1998 (Treier et al., : 2001 and this was strongly down-regulated in the VAD embryo. Bmp2 is expressed in the epithelium of Rathke's pouch itself (Treier et al., 1998 (Treier et al., : 2001 and this was down-regulated. Nkx2.1 expression in the ventral diencephalon is required for Fgf8 maintenance in the same region (Ericson et al., 1998; Takuma et al., 1998) and both of these were also down-regulated. Thus many of the known key players in the early steps of pituitary gland development are under the control of RA. Again, as has been occasionally seen in eye development, both an excess and a lack of RA can cause the same phenotype and in the case of the pituitary excess RA has also been reported to cause an inhibition of its development (Eagelson et al., 2001 ).
In conclusion we have shown through the use of the VAD quail embryo that RA signalling is required for the development of the ventral region of the eye and Rathke's pouch. This model in which the ligand, RA, is absent provides a simple system with which to overcome the problem of RA synthesising enzyme redundancy, a problem which may hide regions of the embryo requiring RA signalling.
Materials & Methods
Embryos
Fertilised hen's eggs and quail's eggs were obtained from a local farm supplier. VAD quail eggs were obtained from a colony kept at King's College London. The adults in this colony were fed a diet devoid of any vitamin A except for the addition of 10 mg/kg all-trans-retinoic acid to the diet. All embryos were incubated at 37ºC and staged according to Hamburger and Hamilton (Hamburger and Hamilton 1951) .
In situ hybridisation
After fixation of the embryos in 4% paraformaldehyde, wholemount in situ hybridisation was carried out according to standard protocols using digoxigenin labelled probes from plasmids available in the laboratory. The Vax2 and Tbx5 probes were kindly provided by Dr C. Cepko. After in situ hybridisation embryos were placed into 80% glycerol and were either studied and photographed whole, after mid-sagittal sectioning or after vibratome sectioning at 80 µm. For gene expression analyses 3-5 embryos per stage per gene were used.
Histology
Embryos were sectioned at 1 µm in plastic using a Technovit 8100 resin kit (TAAB laboratories).
